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MEGAKARYOCYTE-BONE CELL INTERACTIONS:  THE ROLE OF GAP JUNCTIONS, 
MATURATION, AND LONGEVITY. Wendy A. Ciovacco, Carolyn G. Goldberg, Amanda F. Taylor, 
Justin M. Lemieux, Henry J. Donahue, Ying-Hua Cheng, Mark C. Horowitz, and Melissa A. Kacena. 
Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN. 
Research shows that megakaryocytes (MKs) can enhance bone volume by increasing osteoblast 
(OB) proliferation and inhibiting osteoclast (OC) formation. This cumulative work first explores the role of 
gap junction intercellular communication (GJIC) in MK-OB interactions, and secondly examines the effect 
of MK maturation state and MK number on skeletal homeostasis. In both studies, cell lineages were 
cultured as described below. In the gap junction (GJ) study, we used real-time PCR to test for MK 
expression of connexin 43 (Cx43), the predominant GJ protein found in bone cells. A dual-label parachute 
assay and FACS analysis assessed GJIC between MKs and OBs. Proliferation and differentiation assays of 
OBs cultured with and without MKs were performed. Here we demonstrate that: 1) MKs express Cx43, 2) 
MKs can functionally communicate with OBs via GJIC, 3) the addition of two distinct GJ uncouplers 
inhibits this communication, 4) inhibiting MK-mediated GJIC further enhances the ability of MKs to 
stimulate OB proliferation and, 5) blocking GJIC does not result in MK-induced reduction of OB 
differentiation. In the second study, increasing numbers of MKs were co-cultured with bone cells to see if 
increased MK number correlated with increased OB proliferation and decreased OC formation. In addition, 
MKs were separated using flow cytometry into 3 subpopulations based on maturation and effects on OB 
proliferation and OC formation were assessed.  Finally, longevity studies on wild-type and mutant MKs 
were also conducted. In the second study we show that: 1) increased MK number corresponds with 
increased OB proliferation and decreased OC formation, 2) MK maturation stage does not alter the effect of 
MKs on bone cell lineages beyond the megakaryoblast stage, and, 3) GATA-1 deficient MKs survive 
longer than wild-type controls. Thus we demonstrate a novel interaction between two cell lineages only 
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 While cells of the hematopoietic and mesenchymal lineage both originate in the bone 
marrow (BM) and are thus intimately related in space, only in the last few decades have 
functional links between the two lineages been sought.  Hematopoietic and mesenchymal cells 
replicate in juxtaposition to each other, suggesting that local secretion of growth factors or 
cytokines by either lineage, or juxtacrine communication by cell contact, may have a direct or 
indirect effect on neighboring cells.  In fact research now shows that these two systems originally 
studied in isolation are in fact functionally connected, with the skeletal system not just housing 
hematopoietic progenitors, but interacting with these cells in a variety of ways.  
MKs are platelet progenitor cells which primarily reside in the BM, and their reciprocal 
relationship with bone cells is one of the burgeoning areas of research just described.  Multiple 
studies have now provided ample in vivo and in vitro evidence showing that MKs affect the 
development and differentiation of both OCs and OBs.  This cumulative work presents two 
independent studies that further the understanding of the MK-bone cell interaction. The first study 
explores GJIC between MKs and OBs, while the second looks at the effect of MK-maturation 
stage and increasing MK number on the ability of the lineage to affect skeletal homeostasis. The 
Methods, Results, and Discussion section are thus divided into two sections labeled GJIC, and 
MK Maturation and Longevity.  
This Introduction begins with a general background discussion of MK-bone cell 
interactions, and then provides a brief, focused opening for both studies. 
 
1. A. Background Information:  
This opening review summarizes the current research on MK-bone cell interactions. It begins 
by describing several mouse models with dysregulated megakaryopoiesis and resultant skeletal 
pathology, then looks at MK-OC interactions in vitro, and finally at the in vitro effect of MKs on 
OBs. 
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1.A.1. In Vivo Evidence: Mouse Models  
 There are currently four known mouse models with dysregulated megakaryopoiesis and 
resultant significant increases in bone volume.  Mice that overexpress thrombopoietin (TPO), the 
main MK growth factor, have an approximate 4-fold increase in BM MK number, and develop a 
concurrent osteosclerotic bone phenotype with increased bone mineral density (BMD) (1-5).  
Mice with a deficiency in the transcription factors GATA-1 or NF-E2, necessary for normal MK 
differentiation, develop marked increases in MK number with a concomitant reduction of platelet 
number, and a tremendous increase in trabecular bone (6-8).  Most recently a novel mouse model 
of platelet-type von Willenbrand disease (Pt-vWD), with a platelet phenotype identical to the 
human form of the disease, showed a marked increase in splenic MK with splenomegaly, and a 
high bone mass phenotype with decreased serum measures of bone resorption (9). 
 
1.A.1.a. TPO Overexpressing Mice 
 Given that TPO is the major MK growth factor, and is essential for lineage proliferation 
and differentiation, it is expected that a mouse model overexpressing TPO show dysregulated MK 
reproduction and maturation.  Perhaps most surprising is the dramatic phenotype manifested in 
these mice, as a myelofibrotic syndrome with osteosclerosis develops by nine months of age in 
mice repeatedly injected with TPO or infected with a viral vector harboring the TPO gene (1-5).  
Mice overexpressing TPO show a marked 4-fold increase in absolute MK number versus 
wild-type controls affecting all stages of differentiation (1, 2).  Additionally, levels of 
transforming growth factor- (TGF-) and platelet-derived growth factor (PDGF) are elevated 2-
fold and 5-fold respectively versus controls (1-5).  TGF- and PDGF are both growth factors 
expressed by MK with proven marked effects on bone cells (10, 11).  This observed increase in 
MK expression of two growth factors, previously identified to stimulate OBs, raised the 
possibility that in this model MK secretion of TGF- and PDGF resulted in the myelofibrotic, 
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osteosclerotic phenotype seen in TPO overexpressing mice.  This hypothesis was supported by 
studies illustrating that in the absence of TGF-, TPO overexpressing mice failed to exhibit the 
characteristic myelofibrotic, osteosclerotic syndrome.  Irradiated, wild-type mice were engrafted 
with TGF--1-/- BM stem cells infected with a retrovirus encoding murine TPO protein to induce 
TPO overexpression, but no myelofibrosis or osteosclerosis developed.  Furthermore, when 
irradiated, wild-type mice were repopulated with wild-type TPO overexpressing stem cells, the 
femurs now showed significant myelofibrosis and osteosclerosis 16-weeks post-transplantation 
(12), clear evidence that the MK secreted growth factor TFG- plays a critical role in the final 
bone phenotype of TPO overexpressing mouse models. 
Another study using transgenic mice constitutively expressing TPO showed predictably 
elevated numbers of MKs, with associated significant increases in plasma levels of both TGF--1 
and osteoprotegerin (OPG) (13).  OPG inhibits osteoclastogenesis and is expressed by MKs (14-
19).  This study implies that along with TGF-, increased secretion of OPG by MKs contributes 
to the myelofibrotic, osteosclerotic phenotype of TPO overexpressing mice.  Similarly, a study by 
Chagraoui et al. (20) implicates the upregulation of OPG and associated inhibition of 
osteoclastogenesis in the pathogenesis of osteosclerosis.  Here, irradiated wild-type or OPG -/- 
mice were repopulated with either wild-type or OPG -/- BM stem cells infected with a retrovirus 
encoding murine TPO protein.  While all mice showed subsequent increases in TGF-1 with 
associated myelofibrosis, only the wild-type recipients (engrafted with wild-type or OPG -/- stem 
cells) showed increased OPG plasma levels with associated osteosclerosis.  As opposed to this 
bone dense phenotype, the OPG -/- recipients (engrafted with wild-type or OPG -/- stem cells) 
instead developed an osteroporotic phenotype (20).  These results suggest that the OPG secreted 
by the transplanted BM stromal cells and OB caused the osteosclerosis seen in the wild-type 
hosts.  
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Yet another investigation studied the direct effects of TPO on OC formation in vitro and 
demonstrated a TPO dose-dependent decrease in OC number (21).  This effect was most likely 
mediated by increased MK number in response to increased TPO stimulation. Thus it appears that 
TPO plays an indirect role in bone turnover by its proliferative effect on MK. 
In summation, TPO overexpressing mice exhibit marked increases in MK number with 
simultaneous increases in BMD mediated by various MK secreted cytokines, specifically TFG- 
and OPG. 
 
1.A.1.b. GATA-1 and NF-E2 Deficient Mice 
 Pluripotential hematopoietic stem cells give rise to MKs through a stepwise 
differentiation process, with progression through each phase mediated by specific transcription 
factors, ultimately resulting in terminally differentiated MKs capable of releasing platelets. See 
Figure 1 below.  The selective loss of any of the transcription factors regulating MK 
differentiation results in arrested development and accumulation of cells at the latest stage of 
maturation.  Specifically, the loss of either GATA-1 or NF-E2 transcription factors produces 
dysregulated megakaryopoiesis, with GATA-1 knock-down and NF-E2 knock-out mice both 
displaying marked megakaryocytosis and a paradoxical thrombocytopenia (6, 7).  
 
 
Figure 1: Stages of MK development and required transcription factors 
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GATA-1 transcription factor is one of the six members of the GATA family of zinc-
finger transcription factors (GATA-1 through GATA-6 in vertebrates), with DNA binding 
activity in the C-terminal zinc finger of the single polypeptide chain.  GATA-1, previously 
thought to be necessary exclusively for erythroid lineage development, is now known to play a 
critical role in MK differentiation.  Its expression is restricted to the hematopoietic lineage almost 
entirely, with known expression by multi-potential hematopoietic progenitors, mast cells, and 
MKs (22).  In GATA-1 knock-down models, MK number in the BM and spleen increases 
approximately 10-fold, while the peripheral platelet count is decreased to 15% of wild-type 
controls (23).  We have demonstrated that GATA-1 deficient mice have a higher bone mass than 
controls, displaying more than a 3-fold increase in bone volume and bone formation detectable 
after approximately 4 months of age (8).  At ages over a year, these animals ultimately develop a 
myelofibrotic phenotype (24).  MKs from GATA-1 deficient mice are also less differentiated than 
wild-type MKs.  Compared to normal controls, these MKs are morphologically smaller, they 
show evidence of retarded nuclear and cytoplasmic develoment, and GATA-1 deficient MKs 
express reduced levels of mRNA encoding markers of cellular maturity (23).  
NF-E2 transcription factor is a heterodimeric nuclear protein comprised of two 
polypeptide chains, both belonging to the basic leucine zipper family of transcription factors.  The 
p18 subunit is ubiquitously expressed (25, 26), while the expression of hematopoietic-specific 45-
kDa subunit is restricted to erythroid precursors, MKs, mast cells, and multipotential progenitors, 
similar to GATA-1.  Like the GATA-1 knock-down model, MK number in the BM and spleen of 
adult mice lacking p45 NF-E2 is increased, though not as profoundly (2-5 fold), and a severe 
thrombocytopenia develops due to maturational arrest of MK development, with essentially no 
detectable platelets in the peripheral blood (less than 5% of control levels) (6).  Interestingly, we 
have shown that NF-E2 deficient mice also develop a high bone mass phenotype, with up to a 5-
fold increase in bone volume and bone formation parameters (8, 27).  NF-E2 deficient mice 
respond to exogenous TPO with marked proliferation, but there is no detectable increase in 
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platelet production in vivo; and although MK number is markedly elevated, TPO levels are 
normal in NF-E2 deficient mice (6, 28). 
Mice deficient in GATA-1 and NF-E2 transcription factors necessary for proper MK 
differentiation have strikingly similar phenotypes characterized by marked megakaryocytosis, 
thrombocytopenia, and significantly increased BMD. 
 
1.A.1.c Murine Model of Pt-vWD  
 Suva et al. (9) recently developed a mouse model of Pt-vWD by creation of a transgenic 
cassette containing the human Pt-vWD point mutation (G233V) capable of expression in a 
murine colony.  This gain of function mutation affects the GP-Ib subunit of the platelet 
glycoprotein Ib-IX receptor complex which normally binds von Willebrand factor and promotes 
platelet adhesion during vascular damage.  A limited number of mutations such as G233V are 
known that alter the glycoprotein receptor complex configuration while still allowing interaction 
with soluble von Willebrand factor, and this is the pathogenesis behind Pt-vWD (9).  
 The Pt-vWD mutation causes a phenotype in mice that mirrors the human disorder, with 
platelet dysfunction and resultant impaired hemostasis.  The G233V mutant mice have a modest 
thrombocytopenia, with platelet counts reduced by 20%, and significantly increased bleeding 
time versus wild-type mice expressing the normal human GP-Ib subunit.  Mutant mice were 
also found to have spleens that were 2.5 times as large as wild-type controls, leading investigators 
to histological evaluation and discovery of a tissue-specific megakaryocytosis with marked 
increase in splenic MK number. The observation of MK dense spleens prompted an evaluation of 
the mouse BM to determine if MK dysregulation was affecting skeletal homeostasis. While there 
was no increase in the number of MKs in the BM of the mutant mice, histological examination 
revealed a high bone mass phenotype detectable as early as 2 months, and bone mass 
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progressively increased with age.  Mutant bones also exhibited increased biomechanical strength 
versus wild-type controls (9).  
Further BM analysis revealed a decrease in OC number, with no matched decrease in 
OBs, suggesting the high bone mass phenotype was attributable to decreased OC number and 
resultant decreased bone breakdown.  Additionally, ex vivo cultures further demonstrated that 
BM cultures from the Pt-vDW mice had a significant decrease in the number of tartrate resistant 
acid phosphatase (TRAP)-positive OC-like cells versus wild-type controls (TRAP is a biomarker 
of OC number).  Ex vivo cultures failed to show a difference in OB number or differentiation 
versus wild-type controls (9). 
The investigators attempted to identify expression of the GP Ib-IX receptor complex on 
OC to determine if the Pt-vWD mutation was having a direct effect on OC proliferation, but 
transcript profiling and immunofluoresence failed to find GP-Ib-IX expression by OCs.  This 
supports prior evidence that the receptor complex is expressed exclusively on platelets as an MK 
lineage specific gene product (9).  
 The Pt-vWD murine model displays a phenotype similar to the human disease it was 
designed to mimic.  In addition to disrupted hemostasis, these mice have increases in splenic MK 
number, increased BMD, and a decreased number of OCs.  Although the exact mechanism by 
which this tissue-specific megakaryocytosis contributes to decreased OC population and 
decreased osteoclastogenesis remains to be elucidated, this study further confirms the specific 
links between MK function, platelet development, and OC proliferation and differentiation (9).   
 Taken collectively, the four mouse models detailed above illustrate the complex role of 
MK in regulating skeletal mass, and show that disruptions in various points of MK differentiation 





1.A.2. MK-OC Interactions 
 MKs have the ability to directly and indirectly affect osteoclastogenesis, as evidenced by 
recent studies.  The direct effects of MKs on OC differentiation are complex because MKs 
express proteins that both enhance and inhibit osteoclastogenesis.  RANKL is critical for OC 
development, and while it is thought that OBs and OB precursors account for the majority of 
RANKL found within the BM, MKs have also been shown to express RANKL (14, 19, 29, 30).  
However MKs can also inhibit osteoclastogenesis as studies have demonstrated that MK express 
or secrete several factors known to downregulate OC terminal differentiation, specifically OPG 
(an antagonist of RANK signaling), interleukin (IL)-10, IL-13, TGF- and 
granulocyte/macrophage colony-stimulating factor (GM-CSF) (11, 14-18, 31-34).  Thus, MKs 
have the potential to significantly affect OC number through their expression of factors that both 
promote and retard osteoclastogenesis.  Of importance, our group as well as others, have 
demonstrated that when OC progenitors are cultured with MKs or in MK-conditioned medium, in 
vitro OC development is significantly inhibited by up to 10-fold (21, 31, 35).  We also 
demonstrated that OPG expression alone is not responsible for this inhibition, as MKs derived 
from OPG deficient mice also inhibit OC formation in vitro (31).  As a result, we are currently 
working to isolate and identify the MK-secreted OC inhibitory factor using biochemical 
separation techniques including HPLC.  We have identified a single fraction with strong 
inhibitory activity containing less than 30 proteins.  Interestingly, none of the major factors 
known to inhibit osteoclastogenesis, namely OPG, IL-4, IL-10, IL-12, IL-13, IL-18, interferon 
gamma (IFN-), TGF, GM-CSF, OC inhibitory lectin (OCIL), calcitonin, amylin, and calcitonin 
gene-related peptide, are present in the isolated fraction (31).  Therefore while direct, in vitro 
evidence of MK-induced inhibition of OC development exists, the factor(s) or mechanism 
responsible remains unknown. 
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 MK can also indirectly influence osteoclastogenesis.  MKs increase OB and fibroblast 
proliferation by direct cell-to-cell contact (8, 36-40).  OBs and fibroblasts are cells with known 
effects on osteoclastogenesis, including the expression of RANKL and OPG (41-48).  In addition 
to increasing OB proliferation, MKs increase OB expression of OPG when co-cultured (14).  As 
described previously, OPG inhibits osteoclastogenesis, so a potential indirect path for MK 
inhibition of OC formation exists. 
 In conclusion most direct and indirect evidence suggests that MK act to inhibit the 
differentiation of cells of the OC lineage.  MK express numerous proteins known to inhibit OC 
formation, co-culturing MK with OC progenitors results in significant inhibition of OC 
formation, and MK indirectly increase OPG secretion by both OBs and fibroblasts.  However, 
under certain physiological circumstances MK expression of RANKL may be an important 
stimulator of osteoclastogenesis, particularly during inflammatory responses such as rheumatoid 
arthritis (49). 
 
1.A.3. MK-OB Interactions 
 Studies have shown that MKs affect OB development by the secretion of bone matrix 
proteins and growth factors, and by directly increasing OB proliferation.  
MKs or their platelet products secrete multiple bone matrix proteins, namely: osteocalcin, 
osteonectin, bone sialoprotein, and osteopontin (50-54).  MKs also secrete multiple growth 
factors crucial for bone remodeling, including: TGF-1, PDGF, VEGF, and bone morphogenetic 
protein (BMP)-2, -4, and -6 (10, 11, 55).  Therefore MKs could impact bone formation and bone 
remodeling, especially in the setting of elevated local concentrations. 
 Our in vitro evidence demonstrates that MKs enhance OB proliferation 3-6 fold by a 
direct cell-to-cell contact mechanism (8).  Additionally, co-cultures of MKs with BM stromal 
cells also enhances osteoblastogenesis, again by a mechanism requiring direct cell-to-cell contact 
10 
(36).  Although these data demonstrate that MKs mediate OB proliferation by a juxtacrine 
signaling mechanism, the exact method remains to be identified.   
 
1.B. GJIC and MK Maturation and Longevity 
 As the above review shows, it is now imminently clear that the hematopoietic and bone 
lineages are connected not just by proximity, but by functionality, and that MK induced effects on 
OB and OC are multiple and complex.  Several mouse models demonstrate that alterations and 
increases in cells of the MK lineage can lead to increases in bone volume in vivo; and, in vitro 
data shows a primarily inhibitory effect of MKs on OCs, and substantial pleiotropic effects on 
OBs.  However, the exact mechanisms of inhibition and induction need to be further elucidated.  
 
1.B.1. GJIC  
Our previous studies showed that not only does MK conditioned medium fail to enhance 
OB proliferation (8), but that when separated from OBs by a 0.1m membrane in a transwell co-
culture system, MKs again do not increase OB proliferation (8) .  These data suggest that MK 
secreted factors such as cytokines or growth factors are not responsible for the induction in OB 
proliferation, but rather MKs stimulate OB proliferation through some sort of direct cell-cell 
contact, or juxtacrine, mechanism.  There are 3 basic juxtacrine mechanisms: 1) a protein on one 
cell binds its receptor on another cell, 2) a receptor on one cell binds to its ligand on the 
extracellular matrix secreted by another cell and, 3) cytoplasm from one cell is directly to the 
cytoplasm of a second cell.  GJIC is an example of the latter mechanism.  Because GJIC can also 
be blocked with 0.4 m membranes (unpublished observation, H.J.D. and A.F.T.) and because 
Cx43, the predominant GJ protein expressed by bone cells, has been immunolocalized in MKs 
(56), GJIC could also be responsible for the MK-induced enhancement in OB proliferation.  
Therefore, in this study we wanted to determine whether MKs are capable of communicating with 
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OBs through GJs, and whether MK-mediated GJIC is responsible for the MK-induced 
enhancement in OB proliferation.   
 
1.B.2. MK Maturation and Longevity 
As detailed above, there are several well-studied mouse models with dysregulated 
megakaryopoiesis and resultant high bone mass phenotypes. Until now, most theories attempting 
to explain the high bone mass phenotype in the aforementioned mouse models focused on the 
increase in MK number, with the logical assumption that if MKs favor bone deposition, more 
MKs equates to a higher bone mass. Here we test this hypothesis, but also probe further and 
examine MKs cultured from GATA-1 deficient mice to see if there is an inherent quality about 
the mutant cell lineage itself, such as stage of maturation or increased viability, that favors net 
bone formation more than wild-type MKs.  
12 
2. STATEMENT OF PURPOSE 
Hypothesis: 1) That MKs can communicate with OBs by gap junction intercellular 
communication and that this communication influences OB proliferation; 2) the state of MK 
maturation affects bone homeostasis, with immature MKs favoring bone deposition more than 
well-differentiated states; 3) GATA-1 deficient MKs live longer than wild-type counterparts, 
contributing to increased bone deposition 
Aims: 
1) Determine if MKs express Cx43 
2) Determine if MKs and OBs communicate by GJIC 
3) Determine the effect of MK-mediated GJIC on OBs 
4) Determine if MKs sorted by maturation state have different effects on the OB and OC 
lineages 
5) Determine if increasing MK number in co-culture with bone cells further increases OB 
proliferation and or decreases OC development 








3.A.1. Preparation of Fetal Liver Derived MKs: 
Murine MKs were prepared as previously described (8, 31).  In brief, fetuses were 
dissected from pregnant mice at E13-15.  The livers were removed and single cell suspensions 
made by forcing cells thru sequentially smaller gauge needles (18G, 20G, 23G).  Cells were 
washed 2x with DMEM + 10% FCS and then seeded (5 fetal livers/100 mm dish) in 100 ml 
culture dishes, in DMEM + 10% FCS + 1% murine TPO (5).  After 3-5 days, when the cells 
become confluent, MK were obtained by separating them from the lymphocytes and other cells 
using a one-step albumin gradient to obtain a 95% pure MK population (57). The bottom layer 
was 3% albumin in PBS (Bovine Albumin, protease free, fatty acid poor, Serologicals Proteins 
Inc., Kankakee, IL), the middle layer was 1.5% albumin in PBS, and the top layer was media 
containing the cells to be separated.  All of the cells sedimented through the layers at 1g for 
approximately 40 minutes at room temperature.  The MK fraction was collected from the bottom 
of the tube. 
 
3.A.2. Preparation of neonatal calvarial cells (OB):  
Murine calvarial cells were prepared as previously described (58,59).  Briefly, calvaria 
from mice less than 48 hours old were pre-treated with EDTA in PBS for 30 min.  The calvaria 
were then subjected to sequential collagenase digestions.  Cells were collected following 
incubation in collagenase.  Fractions 3-5 were used as the starting population.  These cells were > 
95% OB or OB precursors by a variety of criteria (58, 60, 61). Freshly prepared OBs were used 
for all studies.   
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3.A.3. MEG-01 Cell line: 
MEG-01 cells (ATCC, Rockville, MD) are a human megakaryoblastic cell line which 
was established from the BM of a patient with chronic myelogenous leukemia.  MEG-01 cells 
express the MK marker platelet glycoprotein (GP) IIB/IIIa on their cell surface and possess no 
markers for B or T lymphocytes or for myeloid cells (62). MEG-01 cells were grown in RPMI 
1640 supplemented with 10% FCS.  MEG-01 cells were collected from maintenance culture, 
washed, and used in the parachute assay as described below (MEG-01 cells as well as primary 
MKs were utilized). 
 
3.A.4. RNA Extraction and Real-Time PCR:     
Cells were washed 2-4 times with PBS prior to RNA isolation.  RNA was isolated from 
the cells using trizol (Invitrogen Corporation, Carlsbad, CA) or a NucleoSpin II RNA Purification 
kit (BD Biosciences, San Jose, CA) incorporating an on-column DNase treatment to remove 
contaminating genomic DNA.  For real-time PCR, cDNA was prepared from 5g of total RNA 
using Sprint PowerScript Reverse Transcriptase (BD Biosciences) and oligo(dT)12-18 primers.  
The cDNA was purified using an Amicon YM30 filter device (Millipore, Danvers, MA).  
Alternatively, cDNA was prepared from 2g of total RNA using High-Capacity cDNA Reverse 
Transcription Kits (Applied Biosystems, Foster City, CA).  Quantitative real-time PCR was 
performed on a Cepheid Smart Cycler or on a 7500 Fast Real-Time PCR System (Applied 
Biosystems) using Platinum Taq polymerase (Invitrogen Corporation) and Sybr Green I 
(Invitrogen Corporation) incorporation or using the Power Sybr Green PCR Master Mix (Applied 
Biosystems), respectively. 
The quantitative comparison between samples was calculated using comparative CT.  The 
data are normalized by subtracting the difference of the threshold cycles (CT) between the gene of 
interest (e.g. Cx43) and the CT of the housekeeping gene glyceraldehyde 3-phosphate 
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dehydrogenase (GAPDH).  This value is defined as the CT.  To compare the relative expression of 
Cx43 in two types of cells (e.g. primary C57BL/6 MKs vs. primary C57BL/6 OBs) the CT must 
be calculated.  CT for this example is the absolute value of the difference between the CT for the 
MK and the OB or CT MK - CT OB.  The relative difference (fold increase or decrease) in 
expression is calculated as 2-CT.  The following primer sequences were used: 
Cx43 forward primer:                 5’ CCTTTGACTTCAGCCTCCAA  
Cx43 reverse primer:     5’ CATGTCTGGGCACCTCTCTT  
Osteocalcin forward primer:    5’ AAGCAGGAGGGCAATAAGGT 
Osteocalcin reverse primer:    5’ TTTGTAGGCGGTCTTCAAGC 
Alkaline phosphatase forward primer:              5’ GCTGATCATTCCCACGTTTT 
Alkaline phosphatase reverse primer:               5’ CTGGGCCTGGTAGTTGTTGT  
Type I collagen forward primer:   5’ CAGGGAAGCCTCTTTCTCCT 
Type I collagen reverse primer:                5’ ACGTCCTGGTGAAGTTGGTC 
GAPDH forward primer:    5’ CGTGGGGCTGCCCAGAACAT  
GAPDH reverse primer:    5’ TCTCCAGGCGGCACGTCAGA 
 
3.A.5. Dual-Label Parachute Technique and FACS Analysis: 
 To assess GJIC in co-cultures containing MKs (or MEG-01 cells) and OBs, we utilized a 
dual-label parachute technique which has previously been described (63).  Our protocol was 
adapted from Ziambaras et al (64).  In brief, donor cells (MKs) were simultaneously labeled with 
10 M calcein-AM (Invitrogen Corporation) and 10 M  1,1’-dioctadecyl-3,3,3’,3’-
tetramethylindocarbocyanine perchlorate (DiI, Invitrogen Corporation) for 25 minutes at 37C.  
Cells were washed once in HBSS and once in PBS prior to dropping onto receiving cells (OBs 
were ~90-95% confluent).  Cultures were incubated for 75 minutes at 37C.  It should be noted 
that the number of donor cells (MKs) was titrated in initial experiments from 2,000-200,000 
cells/well.  This titration demonstrated that 20,000 cells/well was in the dynamic range and was 
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used for subsequent parachute assays.  
 Prior to conducting FACS studies, the parachute assay was examined microscopically to 
confirm transfer of dye from MKs to OBs.  Visual inspection confirmed the viability of both the 
donor and receptor cells and demonstrated that the dye-transfer was specific.  The double labeling 
of the MKs with DiI is a secondary confirmation that the donor cells are viable and that dye is not 
permeating from the cells.  As a result of these initial demonstrations (data not shown) we then 
proceeded to conduct FACS analysis. 
For FACS analysis studies, cells were trypsinized to release OBs (during washes most of 
the MKs were removed, remaining MKs were gated out) and cells were fixed in 4% 
paraformaldehyde, resuspended in FACS buffer, and FACS analyzed on a Facstar Plus Flow 
Cytometer (Becton Dickinson, Franklin Lakes, NJ).  Because the calcein is able to permeate gap 
junctions, any OBs which fluoresce green have had calcein transferred to them through GJs.  
Because DiI can not permeate, cells which fluoresce red are the originally labeled donor cells 
(MKs).    In all FACS studies strict threshold controls were employed, according to the method 
previously published (65), to insure that only specific dye transfer was detected.  First, although 
MKs are nonadherent and were washed from the OBs prior to FACS, as a precaution we did have 
a donor control (positive control) containing double labeled MKs.  We set the thresholds so that 
any DiI (red) labeled cells were excluded.  Second, OBs cultured alone served as our negative 
control to which we applied a second threshold to exclude 99.5% of unlabeled OBs.  Cells that 
fell in to the gate set between these 2 thresholds were deemed to be calcein positive OBs that had 
communicated with MKs.  
 In some experiments, cells were treated with increasing concentrations of 18-
glycyrrhetinic acid (GA, Sigma, St. Louis, MO) or oleamide (Sigma) to assess the ability of a 
GJ uncoupler to inhibit MK-OB GJIC.  Here, GA or oleamide was added to the receiving OBs 
30 minutes prior to dropping donor cells (MKs also pretreated with inhibitors) into cultures. 
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3.A.6 Proliferation Analysis: 
    To examine the proliferative capacity of OBs (2500 OBs/well, optimal, pretested) 
cultured with and without MKs (5000 MKs/well, optimal, pretested) that were exposed to GA 
(50 M, optimal, pretested) or vehicle control (DMSO), cells were seeded in triplicate into 96-
well tissue culture plates and incubated for up to 6 days at 37C in -MEM supplemented with 2% 
FCS.  In all of the proliferation studies, as in the parachute assay studies, both MKs and OBs 
were pre-incubated with inhibitors (or vehicle control) for 30-60 minutes prior to seeding.  As has 
been described by Davidson et al (66), our preliminary studies demonstrated that the inhibitory 
response of GA was reduced in 10% FCS as compared to 2% FCS (data not shown); therefore, 
for these studies 2% FCS was utilized.  Proliferation was measured every 2-3 days by the 
incorporation of 3H-thymidine (1 Ci/well; 5-8 Ci/mmol) added during the last 16 hours of 
culture (67).  To assess OB proliferation alone, MK were removed from wells (4 washes) prior to 
measuring incorporation of 3H-thymidine (8).  
 
3.A.7. Differentiation Studies *: 
To examine the differentiation of OBs (20,000 OBs/ml, optimal, pretested) cultured with 
and without MKs (25,000 MKs/ml, optimal, pretested) that were exposed to GA (40-50 M, 
optimal, pretested) or vehicle control (DMSO), cells were seeded in triplicate into either 6-well or 
24-well tissue culture plates and incubated for up to 14 days at 37C in -MEM supplemented 
with 2% FCS and 50 g/ml ascorbic acid on day 0.  It should be noted that cells were only fed 
only 1X/week (day 7) and at this time point fresh MKs were added as non-adherent MKs were 
removed with feeding.  On the day 7 feed, fresh ascorbic acid and αGA/vehicle were added to 
cultures and they were additionally supplemented with 5mM -glycerophosphate to induce 
mineralization.  Differentiation experiments ended on day 14 when mineralized nodules were 
evident in control OB cultures. 
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To assess the effects of MKs on OB differentiation, gene expression levels of alkaline 
phosphatase, type I collagen, and osteocalcin were measured in OBs using real-time PCR.  In 
addition, functional assays for alkaline phosphatase enzyme activity and mineralization were also 
performed.  With regard to real-time PCR, studies were conducted as outline above with the 
following alterations.  Cultures were washed with PBS 4x to remove MKs and these real-time 
PCR experiments were performed using the Applied Biosystems platform. 
 
3.A.8. Alkaline Phosphatase Activity*: 
Alkaline phosphatase activity was determined by the colorimetric conversion of p-
nitrophenol phosphate to p-nitrophenol (Sigma) and normalized to total protein (BCA, Pierce, 
Rockford, IL) (68).  Briefly, cells were washed 2x with PBS, subsequently lysed with 0.1% 
(vol/vol) Triton X-100 supplemented with a cocktail of broad-range protease inhibitors (Pierce), 
subjected to two freeze-thaw cycles, and cleared via centrifugation.  Lysates were incubated with 
3 mg/ml p-nitrophenol phosphate in an alkaline buffer (pH 8.0) (Sigma) for 30 min at 37°C, the 
reaction was stopped by the addition of 20 mM NaOH and read at 405 nM (GENios Plus, Tecan, 
San Jose, CA).  The enzymatic activity of alkaline phosphatase was determined by comparison 
with known p-nitrophenol standards (Sigma). 
 
3.A.9. Quantative Analysis of Calcium Deposition *:  
Calcium deposition was assessed by eluting Alizarin Red S from cell monolayers as 
previously described by Stanford et al (69).  Briefly, monolayers were washed 2x with PBS, 
subsequently fixed in ice cold 70% (v/v) ethanol for 1 hr, and then washed 2x with water.  
Monolayers were stained with 40mM Alizarin Red S (pH 4.2) for 10 min (room temperature, 
shaking), unbound alizarin red was removed by washing with water (5x) and with PBS (1x for 15 
minutes, room temperature, shaking).  Bound Alizarin Red was eluted by incubating monolayers 
with 1% (v/v) cetylpyridinium chloride in 10mM sodium phosphate (pH 7.0) for 15 min (room 
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temperature, shaking).  From aliquots, absorbance was measured at 562 nm (GENios Plus, 
Tecan), and Alizarin Red concentrations were calculated from measured standards (Ca/mol of 
dye in solution). 
 
3.A.10. Statistical Analysis:  
 Two-way factorial analyses of variances were used to compare groups, with MKs and 
αGA being the independent variables.  In the event of a significant interaction, pair-wise 
Bonferroni comparisons were made to explore individual group differences while controlling for 
the elevated family-wise error associated with performing multiple comparisons. All analyses 
were performed with the Statistical Package for Social Sciences (SPSS 6.1.1; Norusis/SPSS Inc., 
Chicago, IL) software and were two tailed with a level of significance set at 0.05. 
 
3.B. MK Maturation and Longevity 
3.B.1.Mice: 
For these studies GATA-1 deficient and C57BL/6 mice were used. Generation and 
breeding of mutant mice with selective loss of GATA-1 was described previously (7, 70).  In 
brief, a DNAse I-hypersensitive region (HS) was identified upstream of the GATA-1 promoter 
and was subsequently knocked-out by insertion of a neomycin-resistant cassette. This resulted in 
mice with reduced levels of GATA-1 mRNA and protein (3-5 fold reduction in protein), a 
functional knock-down (7, 70) GATA-1 deficient mice are maintained on the C57BL/6 
background.   
 
 
3.B.2. Preparation of Fetal Liver Derived MKs: 
Murine MKs were prepared as previously described in the above section (8, 31). 
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3.B.3. Preparation of MK CM 
To generate MK CM, 1X106 MKs/ml were cultured in -media containing no serum for 
3 days. After 3 days CM was collected, sterile filtered, and stored at -80 C until use. For the 
studies here CM was used at 3%, 10%, and 30% (vol:vol). 
 
3.B.4. Preparation of neonatal calvarial cells (OB):  
Murine calvarial cells were prepared as previously described in the above section. (58-
61). Freshly prepared OBs were used for all studies.   
 
3.B.5. Proliferation Analysis: 
    The proliferative capacity of OBs was examined as previously described in the above 
section (66, 67, 8) 
 
3.B.6. In Vitro OC-like Cell Formation Models *: 
OC-like cells were generated by three previously described methods (71-74). First, co-
cultures containing 2x106 BM cells/ml and 20,000 primary calvarial OB/ml were grown in -
MEM supplemented with 10% FCS and 10-8 M 1,25(OH)2D3.  The media was changed every 
other day for 6-8 days.  Second, 2x106 BM cells/ml were cultured in -MEM supplemented with 
10% FCS and 30 ng/ml of recombinant murine M-CSF (Research Diagnostics Inc., Flanders, NJ) 
and 50 ng/ml of recombinant human RANKL (Research Diagnostics Inc.). Media was changed 
every third day for 6-9 days (until OC were visible).  Third, a new OC generation model, using a 
Pax5-/- spleen cell line (SCL) as the source of OC precursors, was used as has been previously 
described (73).  In brief, the Pax5-/- SCL is highly enriched in OC precursors and when cultured 
with M-CSF and RANKL, OC develop in a shorter time (3-4 days) than C57BL/6 BM cell 
cultures (6-8 days).  As detailed by Horowitz et al. (73) the Pax5-/- SCL is 97% CD11b+ (Mac-1), 
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96% CD16/32+ (FcR), and >90% CD115+ (c-fms) as demonstrated by FACS analysis.  In 
addition, the Pax5-/- SCL does not express CD19, CD45R (B220), CD117 (c-kit), Ly-6A/E, Ly-
6C, Ly-6G (Gr-1), NK1.1, or TCR (TCR).  These data indicate that the Pax5-/- SCL expresses 
a monocyte/macrophage-like phenotype with no T or B cells present (73).  For experiments using 
the Pax5-/- SCL, 100,000 cells/ml were cultured with M-CSF and RANKL (as above) and if 
necessary the media was changed on the third day.  Cells were usually fixed at day 4 or 5, stained, 
and counted as described below.     
 
3.B.7. Flow Cytometry *:    
Fetal liver cells were removed from dishes prior to BSA gradient separation as described 
above and washed with PBS containing 2% FCS.  Staining was performed in PBS with 2% 
serum.  Anti-CD41, CD61, CD49b, and CD49d, were purchased from PharMingen.  Anti- CD42d 
was purchased from RDI.  Light scatter and fluorescence of individual cells was measured by a 
Facstar Plus flow cytometer, and cells were sorted base on their antigen expression as described 
here.  Cells were sorted into 3 separate subpopulations (in order of increasing maturity): 
megakaryoblast, MK immature, and MK mature.   
Megakaryoblasts are CD61+ CD41-cells (75, 76).  Anti-mouse CD41 and CD61 
antibodies were obtained from PharMingen. 
Immature MKs are CD41+ CD49d+ cell (77).  Anti-mouse CD49d were also obtained 
from PharMingen. 
Mature MKs are CD41+ CD49b+ (77) or CD41+ CD42d+ (77) cells.  Anti-mouse CD49b 
and CD42d antibodies were purchased from PharMingen and Research Diagnostics, Inc (RDI, 
Flanders, NJ), respectively. 
These 3 subpopulations of cells were then analyzed for their ability to induce OB 
proliferation or inhibit OC formation as described above.  
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3.B.8. Longevity Studies *:   
 C57BL/6 and GATA-1 deficient MKs (40,000 cells/ml) were cultured in the presence or 
absence of TPO (100 ng/ml) and with or without OBs (20,000 cells/ml).  In other words, there 
were 4 groups examined for each type of MK:  1) MK alone; 2) MK+TPO; 3) MK+OB; and 4) 
MK+OB+TPO.  Cells were cultured in 24-well culture plates and the media used in these studies 
was -MEM supplemented with 10% FCS.  As MKs can be removed with normal feedings, 
media was replenished 1/week (if counts were performed, feeding followed counting).  
Specifically, for the first feeding, an additional 1 ml of medium was added to cultures.  On the 
second feeding 1 ml of medium was carefully removed from the top on the well using a pipet and 
an additional 1 ml of fresh medium was added to the cultures.  All subsequent feedings were done 
as described for the second feeding.  Fresh TPO was added to the cultures indicated (100 ng).  
Number of viable MKs present in these cultures was recorded.   
 
3.B.9. Statistics 
Unless otherwise stated, all data are presented as the Mean  1 SD.  Student’s t-test was 
used to determine significant differences, with p<0.05 (Systat 6.0 for Microsoft Windows, SPSS 
Inc., Chicago).  Experiments are always repeated, in some cases multiple times. Within individual 














































4.A.1. MKs Express Cx43: 
To determine whether MKs express Cx43, real-time PCR analysis was completed.  As 
described above, the comparative CT method was used to compare Cx43 expression in different 
types of cells.  GAPDH mRNA served as an internal control for the Cx43 mRNA.  mRNA was 
extracted separately from 3 different cultures of fetal liver derived MKs and primary calvarial 
OBs (both from C57BL/6 mice), and the real-time PCR was performed in duplicate.  The results 
shown below in Figure 2 revealed the presence of mRNA for Cx43 in C57BL/6 MKs, although 









Figure 2.  Real- time quantitative PCR analyses show the expression of Cx43 in C57BL/6 MK and OB 
(n=3).  Results are reported as fold change or relative quantitation of target mRNA expression (2-Ct 
method), normalized to an endogenous control (GAPDH) and relative to a calibrator (OB RNA sample).  
Error bars represent the standard error of the mean associated with the ∆∆Ct value. 
 
4.A.2. MKs Form Functional GJs which can be used to Communicate to OBs: 
To determine whether MKs communicate with OBs via GJIC, MKs and OBs were set-up 
in the “parachute assay”, and FACS analysis was performed.  FACS analysis was used to show 
the transfer of calcein to OBs (Figure 3A), demonstrating that MK-OB GJIC occurs.  It should be 
noted that these experiments were also conducted by replacing MKs with the MEG-01 cell line 
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and similar data were obtained (data not shown). 
 
4.A.3. GA and Oleamide Significantly Inhibit MK-OB GJIC: 
Because our data showed that MK-OB GJIC occurs, we wanted to confirm that MK-OB 
GJIC was specific.  This was accomplished by using two GJ uncoupling agents, GA and 
oleamide (66, 78).  GA or oleamide were titrated into OB cultures (added to OBs 30 minutes 
prior to dropping MKs onto OBs) and then the cultures were analyzed by FACS analysis as 
above.  Figure 3B shows that GJIC remained unchanged with 10 M of GA.  However, with 20 
- 50 M of GA, MK-OB GJIC was reduced (Figures 3C-3E), and with 100 M of GA, 
significant inhibition of MK-OB GJIC was observed (Figure 3F).  We also performed these 
experiments with MEG-01 cells replacing MKs and similar results were observed (data not 
shown).  In studies where we utilized a different GJ uncoupler we found that both 75 and 90 µM 




Figure 3.  Histograms from FACS analysis of OBs after dual-labeled MKs were dropped onto OBs in 
parachute assay and GJ were allowed to form.  3A shows the percentage of OBs in which calcein-Am was 
transferred from MKs.  3B-2F shows the percentage of OBs in which calcein-AM was transferred from 
MKs when cultures were treated with various concentrations of GA (10-100 M).  The filled profile is 
that of the negative control samples.  The open profile is that of the experimental cells.  In the experimental 
cell population there are many cells which do not uptake dye (overlap with the negative control population) 
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4.A.4. Inhibiting MK-OB GJIC Enhances OB Proliferation In Vitro: 
Next we wanted to determine whether MK-mediated GJIC affected OB proliferation.  
OBs were cultured alone, or were co-cultured with MK and grown for 3 days (similar data were 
obtained when cultures were grown for 4, 5, or 6 days, data not shown).  To examine whether 
GJIC altered OB proliferation, some wells were treated with 50 M of GA (OBs alone and OBs 
co-cultured with MKs).  N=9 for each of the 4 groups.  As we have previously reported and as is 
shown below in Figure 4, addition of MKs to OB cultures significantly enhances OB proliferation 
by greater than 50% over a 3 day period of time (8).  Next, we show that OB proliferation was 
significantly reduced when OBs were cultured with GA in the absence of MKs.  There was 
approximately a 50% reduction in OB proliferation when OB were cultured with GA.  This 
suggests that OBs communicate with each other via GJIC to increase their own proliferation, and 
that GA inhibits this communication, leading to a reduction in proliferation.  Importantly we 
show that when GJIC between MKs and OBs is inhibited by treating co-cultures with GA, OB 
proliferation is enhanced even further than when MKs alone are added to OBs (compared to the 
appropriate control, OB treated with GA, there was approximately a 250% increase in OB 
proliferation).  Although MK-mediated proliferation was increased only a modest 14% in cultures 
containing GA as compared to those without GA, the difference was found to be significant 
(p=0.048).  These data suggest that under normal conditions GJIC between MKs and OBs 
decreases the degree by which MKs enhance OB proliferation, and that blocking GJIC with an 









































Figure 4. Proliferation of OBs was assessed by tritium incorporation.  Proliferation of OBs alone in the 
following culture conditions was assessed: OB, OB+MK, OB+GA, and OB+MK+GA (n=9).  MKs were 
removed via washing prior to analysis and MK cultures alone served as a background control (<200 counts 
were observed, data not shown). Error bars represent standard deviations associated with the mean tritium 
level.  All pair-wise comparisons between groups were statistically significantly different from each other 
(p<0.05).  a=significant difference from OB, b=significant difference from OB+MK, c=significant 
difference from OB+GA. 
 
4.A.5. Effects of MKs and GJIC on OB Differentiation In Vitro: 
To further examine the effects of MKs on OB differentiation and the role of GJIC in 
mediating these effects we cultured 4 groups of cells: OB, OB+MK, OB+GA, and 
OB+MK+GA, and examined the following OB differentiation markers: type I collagen, 
osteocalcin, and alkaline phosphatase mRNA expression, alkaline phosphatase activity, and 
calcium deposition as a marker for mineralization.  For all differentiation studies n=8-9.  It should 
be noted that the OB and OB+MK groups also contained DMSO (vehicle control). 
As illustrated below in Figure 5, a greater than 50% reduction in type I collagen, 
osteocalcin, and alkaline phosphatase gene expression was observed in OB cells when MKs were 
cultured with them (in mineralizing culture medium) for 14 days.  Also shown in Figure 4 was the 
even greater reduction in expression of all 3 genes when cells were cultured with GA.  This 
suggests that GJIC is critical for proper expression of several OB genes.  Interestingly, in contrast 
 a,b 
        a 
     
       a,b,c 
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to the proliferation data, when MKs were added to OB cultures containing GA, expression of 









































Figure 5.  Real- time quantitative PCR analyses show the osteoblastic expression of alkaline phosphatase, 
osteocalcin, and type I collagen in OB, OB+MK, OB+GA, and OB+MK+GA cultures (n=8-9).  MKs 
were removed via washing prior isolation of OB RNA.  Results are reported as fold change or relative 
quantitation of target mRNA expression (2-Ct method), normalized to an endogenous control (GAPDH) and 
relative to a calibrator (OB RNA sample).  Error bars represent the standard deviation associated with the 
mean ∆∆Ct value.  With regard to mRNA expression of a single gene of interest, no significant difference 
was detected when comparing OB+GA vs. OB+MK+GA.  All other pair-wise comparisons between 
groups (single gene of interest) were significantly different from each other (p<0.05). a=significant 
difference from OB (gene of interest only), b=significant difference from OB+MK (gene of interest only).  
 
In addition to mRNA expression of several important OB genes, functional data was 
collected with regard to alkaline phosphatase activity and mineralization.  As seen in Figure 6 
below, alkaline phosphatase activity mirrored gene expression data.  Specifically, OB alkaline 
phosphatase activity was significantly reduced in OBs co-cultured with MKs.  When OBs were 
cultured with GA, alkaline phosphatase activity was further reduced.  Like gene expression, 
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Figure 6.  Alkaline phosphatase activity in OB cells from OB, OB+MK, OB+GA, and OB+MK+GA 
cultures (n=8-9).  MKs were removed via washing prior to alkaline phosphatase determinations.  Results 
are reported as a percentage of OB control cultures (OB).  Error bars represent the standard deviation 
associated with the mean.  With regard to alkaline phosphatase activity, no significant difference was 
detected when comparing OB+GA vs. OB+MK+GA.  All other pair-wise comparisons between groups 
were significantly different from each other (p<0.05).  a=significant difference from OB, b=significant 
difference from OB+MK.  
 
Finally, bound calcium was assessed as a functional measure of mineralization.  As with 
the other measures of OB differentiation, OBs co-cultured with MKs exhibited reduced levels of 
calcium deposition (Figure 7).  When OBs were cultured with GA calcium deposition was 
further reduced.  However, unlike the other measures of differentiation, when MKs were added to 
OB cultures containing GA, calcium deposition significantly increased.  This latter trend is 
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Figure 7.  Calcium deposition in OB cells from OB, OB+MK, OB+GA, and OB+MK+GA cultures 
(n=8-9).  MKs were removed via washing prior to calcium determinations.  Results are reported as a 
percentage of OB control cultures (OB).  Error bars represent the standard deviation associated with the 
mean.  All pair-wise comparisons between groups were statistically significantly different from each other 
(p<0.05). a=significant difference from OB, b=significant difference from OB+MK, c=significant 
difference from OB+GA. 
 
 
4.B. MK Maturation and Longevity 
4.B.1. Effect on MK Number on OB Proliferation 
 To determine if MK number affected the degree of OB proliferation we cultured 
increasing numbers of C57BL/6 and GATA-1 deficient MKs (0, 2500 and 5000) with 2500 OBs, 
and OB proliferation was determined by relative tritium incorporation as outlined above (n=9). 
The results at day 3 are shown in Figure 8 below.  When OBs were co-cultured with 2500 MKs, 
derived from either C57BL/6 or GATA-1 deficient mice, OB proliferation was similarly elevated 
by 92% and 91%, respectively.  When OBs were co-cultured with 5000 MKs, derived from either 
C57BL/6 or GATA-1 deficient mice, OB proliferation was enhanced by 127% and 171%, 
respectively.  It should be noted that OB proliferation was significantly increased when co-
cultured with either C57BL/6 or GATA-1 deficient MKs (as compared to OBs cultured alone) at 
both concentrations.  Importantly, although it appears that OB proliferation is further elevated 
  a
  a,b    a,b,c
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when co-cultured with 5000 GATA-1 deficient MKs as compared to 5000 C57BL/6 MKs, no 
significant difference was detected (p=0.11).  Thus, these results show that as MK number 




Figure 8.  Affect of MK number on OB proliferation. Increasing numbers of GATA-1 deficient and 
C57BL/6 MKs similarly enhanced OB proliferation. A significant, greater than 90% increase in OB 
proliferation was observed when OBs were cultured with either 2500 C57BL/6 or GATA-1 deficient MKs. 
Culturing OBs with 5000 MKs further enhanced OB proliferation. * Denotes a significant difference in 
proliferation compared to the OB alone control group, as assessed by the Student’s t-test, where p<0.05. 
 
4.B.2. Effect on MK Number on OC Inhibition 
To determine if MK number affected the degree of OC inhibition we cultured 100,000 
OC progenitor cells/ml with increasing concentrations of C57BL/6 and GATA-1 deficient MK 
CM (0%, 3%, 10%, and 30%, vol:vol), and mature multi-nucleated OC number was determined 
(n=9).  The results are shown in Figure 9 below.  Of note, the OC data presented here utilize the 
Pax5-/- spleen cell line model system as OCs develop in the shortest time with this system and for 
the flow cytometry, we required a model system where OCs were generated in the shortest 
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amount of time (fewer media changes mean fewer sorted MKs required to generated enough 
CM).  We did however demonstrate that in all the OC generation models described, GATA-1 
deficient and C57BL/6 MK CM similarly inhibited OC formation (data not shown and (31)).  
When Pax5-/- OC progenitors were cultured with 3% C57BL/6 MK CM or 3% GATA-1 deficient 
MK CM, there was a 66% and 80% reduction, respectively, in OC formation as compared to OC 
progenitors cultured without CM.  Like with OB proliferation, no significant difference was 
detected between the ability of 3% GATA-1 deficient MK CM and 3% C57BL/6 CM to inhibit 
OC formation (p=0.14).  With 30% MK CM no OCs were detectable in cultures containing 
C57BL/6 or GATA-1 CM.  These results show that just as with OB proliferation, MK number 
















Figure 9. Affect of MK CM concentration on osteoclastogenesis. Increasing concentrations of GATA-1 
deficient and C57BL/6 MK CM similarly inhibited OC development. A significant, greater than 65% 
reduction in the number of OCs formed was observed with just 3% CM. With 30% CM from either 
C57BL/6 or GATA-1 deficient MKs, complete inhibition in OC formation was seen.  * Denotes a 
significant difference in OC number compared to control groups cultured without CM (0%), as assessed by 
the Student’s t-test, where p<0.05. 
 
4.B.3 Effect on MK Maturation Stage on OB Proliferation 
To determine whether the stage of MK maturation influenced OB proliferation, C57BL/6 
MKs were sorted into 3 subpopulations (megakaryoblasts, immature MKs and mature MKs) 
based on antibody binding to cell surface markers characteristic of each subpopulation (flow 
cytometry). 2500 MKs from each individual population, as well as 2500 MKs from a mixed MK 
population (~90-95% pure, BSA separated MK population harvested from fetal livers as outlined 
above (40)), were added to cultures containing 2500 OBs, and OB proliferation was determined 
(n=6). The results are shown in Figure 10 below. Like before, we examined OB proliferation on 
day 3.  Interestingly, the megakaryoblasts had no significant effect on OB proliferation.  
However, the BSA separated MK population, the immature MK population, and the mature MK 
population all had a similar effect on OB proliferation (no significant differences were detected 
between these groups).  Importantly these results show that while megarkaryoblasts have no 
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Figure 10: Affect of MK maturation stage on OB proliferation. 2500 BSA separated C57BL/6 MKs or 
flow cytometry separated immature and mature MKs all similarly enhanced OB proliferation, while 2500 
megarkaryoblasts did not alter OB proliferation. * Denotes a significant difference in proliferation 
compared to the OB control group, as assessed by the Student’s t-test, where p<0.05. 
 
4.B.4. Effect of MK Maturation Stage on OC Inhibition 
To determine whether the stage of MK maturation influenced OC formation, we again 
sorted C57BL/6 MKs into 3 subpopulations (megakaryoblasts, immature MKs and mature MKs). 
These individual subpopulations, as well as the BSA separated MKs, were cultured for 3 days 
(1x106 cells/ml), their CM was collected, sterile filtered, and 3% CM (vol:vol) was added to OC 
generating cultures as before (n=6).  The results are shown below in Figure 11.  To better 
compare to our previous data (Figure 9) all OC results were normalized (control cultures were set 
to 100).  Interestingly, similar to the OB proliferation data, 3% megakaryoblast CM did not alter 
OC formation.  Also like OB proliferation data, 3% CM from BSA separated C57BL/6 MKs, 
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immature MKs, and mature MKs all similarly inhibited OC formation by 63%, 69%, and 65% 
respectively (no significant differences were detected between these groups).  Thus, these results 
show that similar to the OB data, megakaryoblasts have no effect on OC development, but 
immature and mature MKs have virtually the same inhibitory effect on OC development. 
 
 
Figure 11. Affect of MK maturation stage on OC inhibition. 3% C57BL/6 MK CM from BSA separated or 
flow cytometry separated immature and mature MKs similarly inhibited OC development, while 3% CM 
from megakaryoblasts did not inhibit OC development. * Denotes a significant difference in OC number 
compared to OC control group, as assessed by the Student’s t-test, where p<0.05. 
 
4.B.5. Distribution of MK Subpopulations in C57BL/6 and GATA-1 Deficient Fetal Livers 
C57BL/6 and GATA-1 deficient fetal liver cultures stimulated with TPO appear similar 
in their relative distribution of megakaryoblasts and immature MK if they are collected on day 3, 
but on day 4 the distribution is starting to change with an increase in mature MK in C57BL/6 
cultures.  Our flow cytometry data indicated day 4 fetal liver C57BL/6 cultures  (total cells prior 
to BSA gradient separation to enrich for MKs) contained 1.83% of megakaryoblasts, 3.22% of 
immature MKs, and 4.95% of mature MKs, while GATA-1 deficient cultures contained 3.41% of 
megakaryoblasts, 4.58% of immature MKs, and 2.01% of mature MKs (based on equivalent cell 
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numbers).  As would be expected, this data indicates that the C57BL/6 MKs are more 
differentiated than GATA-1 MKs.   
 
4.B.6. MK Longevity: 
 To formally quantify if GATA-1 deficient MKs outlive their C57BL/6 counterparts we 
cultured C57BL/6 or GATA-1 deficient MKs alone, with TPO, with OBs, or with TPO and OBs.  
Viable MK number was recorded until no viable MKs were detected (n=4).  The data from this 
study is presented in Figure 12 below. Virtually all of the C57BL/6 and GATA-1 deficient MKs 
cultured alone died by day 9 in culture (data not shown). The cultures of MKs with TPO added 
fared only slightly better, perhaps extending their lifespan by 2+ days (data not shown). Thus 
without the addition of OBs, viable MKs from both populations were not detected by 
approximately day 9. Interestingly, when MKs were co-cultured with OBs, MK survival was 
increased, but by day 15 virtually no viable MKs were detected (data not shown). However, the 
addition of both TPO and OBs significantly prolonged the lifespan of both C57BL/6 and GATA-
1 deficient MKs. On day 15 when viable MKs were not detected in the other cultures, viable 
C57BL/6 MKs and  GATA-1 deficient MKs were seen in culture containing both TPO and OBs.  
Both MK lineages peaked at day 20 with C57BL/6 MKs averaging 169±55 and GATA-1 
deficient cultures averaging 450±100. After that, C57BL/6 MK number precipitously declined 
and by day 34 no viable MKs were detected. However, while the number of viable GATA-1 
deficient MKs also declined, they significantly outlived their wild-type counterparts.  It was not 
until day 69 that no viable GATA-1 deficient MKs were detected.  It is important to remember 
that in these studies we cultured cells in OB media, not in MK media, which may negatively 
impact MK survival.  That being said, overall these data show that the combination of TPO and 
OBs enhances MK survival, and that GATA-1 deficient MKs survive longer than C57BL/6 MKs 
















Figure 12. Viable MK number over time. C57BL/6 and GATA-1 deficient MKs were cultured alone, with 
TPO, with OBs, or with TPO and OBs, and viable cell number recorded. The combination of OBs and TPO 





GJs are pores or channels that span the cellular membrane and allow molecules less than 
1kD to pass from one cell to another, providing bilateral communication between the cells’ 
cytoplasm. GJs are formed by two hexameric hemichannels, or connexons, composed of six 
protein subunits, termed connexins (Cxs).  There are more than 20 identified mammalian Cxs 
(79), each with a different molecular permeability and a unique capability to interact with specific 
other connexins (80).  Different tissue types express different Cxs, with Cx43 being the 
predominant GJ protein expressed by bone cells. OBs, OCs and osteocytes have all been shown 
to express Cx43, and Cx45 and Cx46 have also been detected (81).  Importantly, one study also 
found MK expression of Cx43 during immunostaining of human and mouse BM biopsies. (56).  
This suggests that MKs may be able to communicate through GJs. Our previous studies have 
shown that MKs can enhance OB proliferation by up to 6-fold in vitro, that MK secreted growth 
factors or cytokines are not responsible for the enhancement in OB proliferation, and that the 
proliferative influence is blocked when the lineages are separated by a 0.1 m membrane. Since 
MKs stained positively for Cx43, and because GJIC can be blocked by 0.4 m transwell 
membranes (unpublished observation, H.J.D and A.F.T.), we investigated whether MKs can 
communicate with OBs through GJs, and whether MK-mediated GJIC was responsible for the 
MK-induced enhancement in OB proliferation we previously reported (8).   
In this study we demonstrated that MKs expressed Cx43 (Figure 2), that functional GJs 
formed between MKs and OBs (Figure 3), and that GJIC between MKs and OBs could be 
significantly inhibited with exposure to a GJ uncoupler, GA (Figure 3).  To our knowledge, with 
the exception of the immunostaining data by Krenacs and Rosendaal (56), this is the first report 
that MKs can form functional GJs, and that GJIC between MKs and OBs occurs and allows for 
the transfer of small molecules from MKs to OBs as demonstrated by the transfer of calcein-AM 
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(Figure 3). 
Interestingly, our data also demonstrated that MK-OB GJIC does not enhance OB 
proliferation, but in fact inhibits it.  As shown in Figure 4, the relative increase in OB 
proliferation when MKs were added was greater in the presence of GA than in the presence of 
vehicle control (250% vs. 53%, respectively) suggesting that using GJ uncoupling agents 
enhances MK-induced OB proliferation.  In these studies 2 separate GJ uncoupling agents were 
used, GA and oleamide.  The mode of action of αGA is complex but is primarily thought to act 
indirectly on the GJ through a series of phosphorylation changes in Cx43.  Oleamide, on the other 
hand, is thought to act by dissolving membrane lipids, changing membrane fluidity, and 
contracting the channel (82, 83). Although 2 separate GJ uncoupling agents were used in this 
study and their modes of action vary, both inhibitors have also been implicated in non-GJ 
signaling pathways as well as in inhibiting GJIC.  Importantly, the fact that our previous studies 
demonstrate that MK conditioned medium is unable to elicit an increase in OB proliferation (8) 
indicates that several of the non-GJ related signaling pathways can be ruled out (e.g. ATP release 
through hemichannels).  Therefore, while not definitive, the combination of the data presented 
here using two separate agents known to strongly inhibit GJIC, as well as the previously 
published data with MK conditioned medium and transwell membrane studies, strongly suggests 
that the inhibitor data is reflective of blocking MK-OB GJIC. 
While our initial goal in this study was to determine whether GJIC was responsible for 
the MK-mediated increase in OB proliferation, to conduct a more rigorous study we also 
examined the influence of MK-mediated GJIC on OB differentiation.  Specifically we examined 
OB expression of type I collagen, osteocalcin, and alkaline phosphatase.  In addition we 
performed 2 functional in vitro assays of alkaline phosphatase activity and mineralization 
(calcium deposition).  Surprisingly, we found that MKs inhibited all markers of OB 
differentiation.  These data were unexpected as Bord et al (14) had previously published findings 
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demonstrating that MKs enhanced OB expression of collagen (COL1 A1) and osteoprotegerin 
(OPG).  These apparent contradictory findings may be explained by experimental differences, 
specifically the duration of the cultures studied.  In their study, OB mRNA was examined 1 day 
following co-culture (14).  In the studies presented here, MKs have been cultured with OBs for 14 
days.  Our cultures had a confluent monolayer with mineralizing nodules present in the OB 
control cultures.  In the study by Bord et al (14), the cultures are much less mature and this 
difference alone could easily account for the apparent discrepancy.  Alternatively, with longer 
culture durations, it is possible that MKs could be causing OBs to undergo apoptosis.  While 
specific apoptosis experiments, such as tunnel staining, were not conducted, three lines of 
evidence suggest that apoptosis is not responsible for the MK-mediated reduction in OB 
differentiation measures.  First, we have previously published that co-culture of OB with MKs for 
6 days resulted in increased numbers of proliferating OB (8).  Second, visual observation of the 
OBs would not suggest an apoptotic or even necrotic action. There was an intact monolayer, there 
were no floating cells to speak of, and cells were piling up and forming normal nodules, just not 
to the extent observed in cultures not containing MKs.  Finally, we had comparable levels of 
soluble protein in OBs from control cultures or cultures containing MKs (data not shown).   
With regard to the influence of GJ uncoupling agents on OB differentiation, when OBs 
were cultured with GA, all of the OB differentiation markers examined were markedly reduced 
(the effect was more pronounced than the MK-mediated reduction).  Thus, in order to ascertain 
the effects of GJIC on MK-mediated alterations in OB differentiation we used the cultures of OB 
treated with GA (OB+GA) as a control for the OB+MK+GA cultures.  When making this 
comparison, MKs did not alter OB mRNA expression of alkaline phosphatase, type I collagen, or 
osteocalcin.  Nor did MKs alter alkaline phosphatase activity in these cultures.  However, there 
was a significant increase in calcium deposition.  It is important to note that although bound 
calcium levels were elevated, microscopic observation demonstrated that while both OB cultures 
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and OB+MK cultures showed typical nodule formation (albeit at lower levels), none of the 
cultures treated with GA (OB+GA and the OB+MK+GA) exhibited typical nodule formation 
(data not shown).  Visually no matrix was observed in the cultures treated with GA.  Therefore 
it is thought that the increase in bound calcium measured in OB+MK+GA cultures as compared 
to OB+GA cultures may be reflective of higher background levels as opposed to actual calcium 
deposition into the matrix.  As indicated in Figure 4, there were significantly more proliferating 
OBs in OB+MK+GA as compared to OB+GA cultures, which could account for the higher 
background levels.  In addition, the measured calcium levels were negligible in cultures treated 
with GA as compared to untreated cultures.  Further, the observation that typical nodule 
formation is reduced in GA treated cultures is consistent with the gene expression and alkaline 
phosphatase activity, suggesting that GA treatment itself inhibits OB differentiation.  Thus, with 
the possible exception of the bound calcium, the OB differentiation parameters evaluated in this 
study were unaltered by GJIC, suggesting that future studies will need to explore alternative 
signaling mechanisms. 
As with most in vitro model systems, there are limitations which must be addressed.  
First, we have taken 2 separate cell types which are present in the BM cavity and cultured them 
together to assess regulatory mechanisms.  Clearly within the marrow cavity there are many other 
cells, most of which can also form GJs (84-87) and the GJ-mediated interactions of these cells 
may also be important in skeletal regulation.  As mentioned earlier, although our data implicates a 
role for GJ in MK-mediated changes in OB proliferation, the GJ uncouplers used here have also 
been implicated in non-GJ signaling pathways.  Finally, although our data clearly demonstrate 
that the relative increase in OB proliferation as stimulated by MKs is higher in cultures treated 
with αGA as compared to those without αGA (250% vs. 53%, respectively), this may reflect that 
MKs can increase OB proliferation by a mechanism independent of GJIC.  Indeed, examination 
of the data contained in Figure 4 demonstrates that OB proliferation is only 14% higher in 
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OB+MK+αGA cultures as compared to OB+MK cultures.  Thus, this data may suggest that MK-
induced OB proliferation can reach a maximum level and that this maximum level is independent 
of GJIC.  However, our statistical analyses indicate that OB proliferation in OB+MK+αGA 
cultures is significantly different from that observed in the OB+MK cultures (p=0.048).  
Specifically, our 2-way factorial ANOVA demonstrates that there is an interaction between MKs 
and αGA indicating that the response to MKs is influenced by the presence of αGA, and vice 
versa.  As described previously, we performed pair-wise Bonferroni comparisons after finding a 
significant statistical interaction to control for the elevated family-wise error associated with 
performing multiple comparisons.  This revealed a p-value of 0.048 and so, although we cannot 
rule out non-GJ signaling pathways, treatment of OB+MK cultures with αGA significantly 
enhances OB proliferation in vitro. 
In conclusion, the data present here demonstrate 4 critical findings.  First, MKs and OBs 
can communicate via GJIC.  Second, both proliferation and differentiation of OBs is inhibited 
when cells are treated with GA.  This finding is consistent with the reports of other investigators 
(88-90). Third, MKs inhibit OB differentiation in vitro when cultured for extended durations.  
Fourth, GJIC inhibits MK-mediated enhancement of OB proliferation but does not appear to alter 
MK-mediated reductions in OB differentiation.  Importantly, these data suggest that specific 
inhibition of MK-OB GJIC may increase OB proliferation.  
 
5.B. MK Maturity and Longevity 
Here we compare characteristics of GATA-1 deficient MKs to wild-type C57BL/6 MKs 
in an attempt to isolate the characteristic(s) of these mutant cells that contributes to the high bone 
mass phenotype seen in GATA-1 deficient mice (8). As much attention has been given to the fact 
that GATA-1 deficient mice have increased MK number, we first cultured increasing number of 
MKs, or increasing concentrations of MK CM, with OBs and OC precursors respectively, to 
study the effect of increased MK number or increased MK CM concentration on bone cells. We 
43 
then looked at the effect of MK stage of maturation on the same populations, and finally looked at 
MK life span.  
As Figure 8 demonstrates, 2500 MKs cause an approximate doubling of the OB 
population, with MKs cultured from GATA-1 deficient and wild-type MK having almost the 
exact same effect. When the number of MKs in co-culture was doubled (5000 MKs), OB 
proliferation increased further, and no significant differences were detected between the ability of 
C57BL/6 or GATA-1 deficient MKs to enhance OB proliferation. Similarly, as Figure 9 shows, 
both C57BL/6 and GATA-1 deficient MK CM were equally able to inhibit OC formation. These 
data, on first glance, appear to support the idea that MK number alone can elicit a response in 
bone cells. 
The next parameter we studied was MK maturation stage. In our previous studies of MK 
effect on OBs and OCs, no attempt was made to separate out MKs based on stage of maturity, yet 
2 of the 4 aforementioned mouse models with high bone mass phenotypes have documented 
defects in MK maturation. Mice deficient in NF-E2 and GATA-1 transcription factors have a 
developmental arrest in MK differentiation, resulting in the accumulation of immature MKs (8).  
Further, immature MKs from NF-E2 deficient mice have significantly reduced numbers of 
granules (6), while the MKs from GATA-1 deficient mice are so immature as to have few if any 
specific granules, inhibiting if not precluding their ability to hold and later secrete proteins like 
wild-type MKs (7). However, in the TPO overexpressing mice, there are increased numbers of 
MKs at all stages of differentiation, and these mice have increased bone mass (3-5).  As the 
former mouse models imply that increases in the number of immature MKs may be a requisite for 
increases in bone mass; perhaps the TPO overexpressing mice have sufficient numbers of 
immature MKs to produce this high bone mass phenotype. MK maturation stage is also an 
important parameter to consider because when we culture fetal livers in vitro for MK isolation, 
C57BL/6 cultures resemble cultures from GATA-1 deficient fetal livers. Our FACS analysis of 
these cultures in vitro demonstrated that at day 3 they were virtually identical (data not shown), 
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and at day 4 some slight differences were seen. Therefore if our in vitro C57BL/6 and GATA-1 
deficient MK cultures are virtually identical in subpopulation distribution, it would not be 
unreasonable for these MKs to elicit a similar response. Thus like our prior assumption with 
GATA-1 deficient and NF-E2 deficient mice, perhaps the reason C57BL/6 MKs induce OB 
proliferation in vitro is because they are a more immature cell population. Here we directly 
address this issue by sorting MKs from C57BL/6 wild-type animals into populations based on 
stage of differentiation, and co-culture these subpopulations with OBs and OCs to study the effect 
of MK maturation on these separated cells. For these studies we examined BSA separated MKs, 
as well as flow cytometry separated megakaryoblasts, immature MKs, and mature MKs. Figures 
10 and 11, respectively show that the degree of OB proliferation induced, or OC formation 
inhibited, was not significantly different if immature MKs, mature MKs, or BSA separated MKs 
were used. Megakaryoblasts, however, had no proliferative effect on OBs nor inhibitory effect on 
OCs.  It should be noted that for these maturation studies we chose to analyze only one time point 
for OB proliferation (day 3), and used only the lower cell number (2500). Similarly, we only used 
the lower concentration of MK CM (3% vol:vol). This was done because recovery of sorted 
subpopulations of MKs was low.  In general it is difficult to sort large cells such as MKs, and 
sorting is done more slowly. Added to this we only obtained approximately 1x106 BSA separated 
MKs per pregnant mouse. These BSA separated MKs are approximately 90-95% immature and 
mature MKs and the contaminating cells are megakaryoblasts and other fetal liver cells (57). 
Thus, many mice and long sorting times are required to obtain sufficient numbers of cells in each 
subpopulation. To further enhance our ability to obtain sufficient numbers of cells in each 
subpopulation we did the following.  We extended our fetal liver culture duration (stimulated 
with TPO) from 3-4 days to 5 days to enhance the number of mature MKs obtained.  On the other 
hand, to enhance megakaryoblasts we cultured fetal liver cells for 3 days without TPO.  This is 
important, as both C57BL/6 and GATA-1 deficient fetal liver cultures stimulated with TPO 
appear similar in their relative distribution of megakaryoblasts and immature MK if they are 
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collected on day 3, but on day 4 the distribution is starting to change with an increase in mature 
MK in C57BL/6 cultures (data not shown). These technical issues aside, it appears that in vitro 
mature and immature MKs equivalently influence OBs and OCs while megakaryoblasts do not 
exert an influence. 
We now turn to our data on MK longevity. Of note, we chose to culture MKs alone, with 
TPO, with OBs, and with TPO and OBs (Figure 12). We thought it vital to co-culture MKs with 
OBs, for just as MKs have a positive proliferative effect on OBs, OBs similarly stimulate 
megakaryopoiesis (8, 36). Since our focus is on the interaction of the hematopoietic and bone cell 
systems, we wanted to create an in vitro environment that more closely resembled the natural in 
vivo BM environment. To our knowledge this is the first formal attempt to quantify MK lifespan 
in vitro when cultured with TPO and OBs. In reference to longevity the most striking data was 
seen when MKs were cultured in the presence of OBs and TPO. In the presence of both OBs and 
TPO, viable C57BL/6 MK number peaked at day 20 and declined precipitously after that, with 
only a few viable MKs present at day 28, and none detected at day 34. This result is in agreement 
with work done by one group who studied MK lifespan in vitro, and found when cultured with 
TPO the number of mature MKs peaked at days 12-15, with the majority of MKs beginning to 
show markers of apoptosis at days 18-21 (23). We found similar results when MKs were co-
cultured with OBs in the presence of TPO, but in the absence of OBs our wild-type MKs did not 
survive as long as the above group reports. This may be explained by the fact that we cultured our 
cells in osteogenic media as opposed to MK culture media. The GATA-1 deficient MK 
population co-cultured with OBs under the influence of TPO also peaks around day 20. Of note, 
the peak observed in both populations is due to the impurity of the population. For approximately 
5-10% of the sample is megakaryoblasts and as they proliferate in response to TPO the 
populations of both wild-type and GATA-1 deficient MKs initially increases, and only begins to 
decline after these cells have presumably finished responding. However, at day 34 when no 
mature C57BL/6 MKs were detected, there were more than 200 viable GATA-1 deficient MKs 
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still present. It was not until day 69 that there were no viable GATA-1 deficient MKs detected. 
Our results are broadly consistent with previous work done by Vyas et al. (23) showing that 
GATA-1 deficient MKs outlive wild-type MKs. Of note, the GATA-1 deficient MKs cultured 
with TPO alone in the study by Vyas et al. (23) lived up to 4-weeks, while our GATA-1 deficient 
MK population cultured with TPO alone did not survive as long, again likely owing to our use of 
osteogenic culture media. However, in the presence of OBs and TPO we saw a marked increase 
in longevity of 103% which was similar to the 100-133% increase in longevity reported by Vyas 
et al. (23) with TPO alone. Thus GATA-1 deficient MKs live significantly longer than their wild-
type counterparts when both are cultured with OBs in the presence of TPO. Interestingly, we 
show here that culturing MKs with TPO and OBs has a synergistic effect on both GATA-1 
deficient and wild-type MK lifespan. For when MKs of either type are cultured with TPO alone, 
there are no viable MK cells by approximately day 9, and with OBs alone there are no viable MK 
cells by day 15. However, when C56BL/6 MKs are cultured with TPO and OB they live up to 34 
days, and GATA-1 deficient MKs survive up to 69 days, highlighting the significant synergistic 
effect of TPO and OBs together on MK survivability. 
Here we confirm prior in vivo observation of mouse models that increased MK number 
corresponds to a high bone mass phenotype by showing that, to an extent, increasing MK number 
further increases OB proliferation and inhibits OC formation. However, here we looked closer at 
the MKs themselves, wondering if in addition to increased number, there was something 
inherently different about GATA-1 deficient MKs that favored net bone deposition more than 
wild-type MKs. We looked at stage of maturation and showed that immature and mature MKs 
have similar effects on osteoblastogenesis and osteoclastogenesis. Finally, we tried to better 
simulate the in vivo BM environment by co-culturing MKs with OBs in the presence of TPO and 
demonstrated that GATA-1 deficient MKs significantly outlive C57BL/6 MKs by up 35 days. 
Thus, in addition to increased MK number, we propose that increased longevity contributes to the 
increased influence of GATA-1 deficient MKs on skeletal homeostasis. If viable MKs are around 
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for a longer duration in the BM cavity, there is more opportunity to stimulate OB proliferation 
and likewise inhibit OC development. Therefore, the increased longevity of GATA-1 deficient 
MKs may partially explain the high bone mass phenotype seen in GATA-1 deficient mice. 
 
5.C. Conclusions 
It is now imminently clear that the hematopoietic and bone lineages are connected not 
just by proximity, but by functionality, and that MK induced effects on OBs and OCs are multiple 
and complex. While the exact mechanisms of inhibition in osteoclastogenesis and induction in 
osteoblastogenesis still need to be further elucidated, here we make important strides toward that 
goal.  
Our first work focused on MK-OB communication, finding that the two lineages are 
capable of interacting by GJIC. While the net overall effect of MKs on OBs is to increase OB 
proliferation, here we found a novel inhibitory reaction. We postulate that GJIC between MKs 
and OBs partially counteracts another juxtacrine mechanism, and showed that when GJIC was 
inhibited, OB proliferation was enhanced even further. In the second study we focused on MKs in 
an attempt to uncover what inherent quality contributes to their osteoblastogenic effect. We 
discovered that mutant GATA-1 MKs significantly outlive wildtype MKs, and that this may 
contribute to the bone mass phenotype observed in the mutant mice.  
By discovering details in the complex interplay of these cells, we take steps towards 
clinical significance with the distant possibility of therapeutic intervention if we could harness the 
osteoblastogenic effect of  MKs. Specifically, in the GJIC study we found a method of increasing 
OB proliferation without altering differentiation, which may provide a potential novel anabolic 
therapeutic treatment approach for bone loss diseases such as osteoporosis.   
 As we continue to unravel the complexities behind the hematopoietic-bone cell interplay, 
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